Trial intelligence / Profile preview

Biomarkers and Almotriptan in Sinus Headache vs Migraine

NCT00208065Phase 4Completed

Sponsor
Clinvest Research
Start
May 2004
Primary completion
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of almotriptan in migraine, sponsored by Clinvest Research. Started May 2004; status: completed.

02

Drugs

almotriptan
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00208065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00208065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call